Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02583906
What this trial is testing

Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment

Who this might be right for
Sleep-Disordered BreathingPulmonary Arterial HypertensionChronic Thromboembolic Pulmonary Hypertension
Universitaire Ziekenhuizen KU Leuven 8
Testing effectiveness (Phase 2)WithdrawnNCT01723371
What this trial is testing

Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children

Who this might be right for
Pulmonary Arterial Hypertension
The Hospital for Sick Children
Not applicableStudy completedNCT07266012
What this trial is testing

Incorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment in Pulmonary Arterial Hypertension: The INVEXUS-PAH Study

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Istanbul University - Cerrahpasa 86
Not applicableStudy completedNCT01317134
What this trial is testing

Endothelial Function in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, PulmonaryPulmonary Arterial HypertensionPathophysiology+1 more
Universitätsklinikum Hamburg-Eppendorf 90
Post-approval studies (Phase 4)UnknownNCT01288651
What this trial is testing

Iron Deficiency In Pulmonary Hypertension

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Amsterdam UMC, location VUmc 30
Testing effectiveness (Phase 2)Study completedNCT03496207
What this trial is testing

Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 106
Not applicableStudy completedNCT01491646
What this trial is testing

Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
National Jewish Health 25
Early research (Phase 1)Study completedNCT01153386
What this trial is testing

Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 36
Not applicableLooking for participantsNCT07137260
What this trial is testing

Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial

Who this might be right for
Pulmonary HypertensionPrecapillary Pulmonary HypertensionRight Heart Catheterisation+1 more
Simon Jäger 77
Not applicableLooking for participantsNCT06968962
What this trial is testing

Comparison of Sequential to Initial Combination Therapy in PAH

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Second Affiliated Hospital, Zhejiang University, School of Medicine 376
Testing effectiveness (Phase 2)UnknownNCT01827059
What this trial is testing

Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE

Who this might be right for
Pulmonary Arterial HypertensionCongenital Heart Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 12
Early research (Phase 1)Study completedNCT04675944
What this trial is testing

Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 20
Testing effectiveness (Phase 2)UnknownNCT01246037
What this trial is testing

Beta-blockers in i-PAH

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Amsterdam UMC, location VUmc 30
Post-approval studies (Phase 4)Study completedNCT03078907
What this trial is testing

Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 108
Large-scale testing (Phase 3)Study completedNCT02471183
What this trial is testing

Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 34
Not applicableStudy completedNCT03102294
What this trial is testing

Inspiratory Muscle Training in Pulmonary Hypertension

Who this might be right for
Chronic Thromboembolic Pulmonary HypertensionInspiratory Muscle TrainingInspiratory Muscle Weakness+1 more
Federal University of São Paulo 32
Early research (Phase 1)Study completedNCT05427253
What this trial is testing

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Who this might be right for
Safety IssuesToleranceIdiopathic Pulmonary Fibrosis+1 more
Vicore Pharma AB 80
Early research (Phase 1)Study completedNCT03489005
What this trial is testing

Effect of BIA 5 1058 on Cardiac Repolarization

Who this might be right for
Cardiovascular DiseasePulmonary Arterial HypertensionHeart Failure
Bial - Portela C S.A. 49
Large-scale testing (Phase 3)Ended earlyNCT00302211
What this trial is testing

The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Actelion 67
Testing effectiveness (Phase 2)Study completedNCT00792571
What this trial is testing

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 18
Next Page